Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Learn what to consider for retirement in your 30s to effectively build wealth and secure your financial future. Start making informed choices now!
18,900 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
This in-depth piece dives into Chile's bold tax reform plan and what it could mean for growth, investment, and global...
AGNC Investment's more than 13.5% yield looks tempting, especially in a low-rate world. Yet looming Fed rate changes ...
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
This article breaks down Quaker Chemical's Q4 2025 earnings implications, real-world drivers, and practical steps you...
A fresh stake from Cross Staff Investments in the Akre Focus ETF could signal a manager’s confidence in Akre’s approa...
PayPal is extending the reach of its USD-backed PYUSD stablecoin to 70 international markets. With PYUSD supply surpa...
As AI tax prep tools surge this season, experts warn that convenience can come with risky gaps. taxpayers weigh speed...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Seeking dependable income in a volatile market? This article highlights three energy dividend stocks reliable for 202...